Sema4: Isaac Ro
Isaac Ro has been appointed as CFO of Sema4. Previously, he was CFO of Thrive Earlier Detection, which was recently acquired by Exact Sciences. Prior to that, he led the US medical technology team at Goldman Sachs, where he covered life science tools, diagnostics, and medical technology. Before that, he held a similar role at SVB Leerink.
Sophia Genetics: Ross Muken
Sophia Genetics has named Ross Muken as chief financial officer. Muken, who has more than two decades of experience in finance, previously had been CFO and COO of Click Therapeutics. He has also had stints as head of healthcare services and technology research at Evercore ISI and in equity research at Thomas Weisel Partners.
Qiagen: Toralf Haag
Qiagen said this week that it has appointed Toralf Haag as a member of the supervisory board and audit committee. Since October 2018 Haag has served as CEO and chairman of management board at Voith, a global technology company. Before joining Voith, he served for more than 11 years at Lonza as CFO and a member of the executive committee.
For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.